Lanean...
Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation
Type I (T1) diabetes is an autoimmune and metabolic disease associated with bone loss. Previous studies demonstrate that T1-diabetes decreases osteoblast activity and viability. Bisphosphonate therapy, commonly used to treat osteoporosis, is demonstrated to inhibit osteoclast activity as well as ost...
Gorde:
| Argitaratua izan da: | J Cell Physiol |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4724196/ https://ncbi.nlm.nih.gov/pubmed/25641511 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcp.24929 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|